Clinical Trials Tech Firm Science 37 to Go Private at Fraction of Past $1B Valuation – MedCity News
Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies from their homes. Decentralized clinical trials…
Continue Reading